Results 151 to 160 of about 22,026 (263)
Food Science &Nutrition, Volume 14, Issue 4, April 2026.Production of peptide molecules from hazelnut cake using proteolytic enzymes and ultrafiltration methods. Exploration of antioxidant activities, DPP‐IV and ACE inhibitory properties of these molecules and their evaluation in food supplement applications.
Sebahat Şişman +3 more
wiley +1 more source
Health Science Reports, Volume 9, Issue 4, April 2026.ABSTRACT Background and Aims Liver cancer is concurrently influenced by a number of risk factors, such as chronic viral hepatitis, heavy alcohol use, and metabolic associated conditions. This study aims to examine whether there are interaction patterns among factors associated with liver cancer risk among patients with diabetes.
Sarah Tsz Yui Yau +6 more
wiley +1 more source
Review of sitagliptin phosphate: a novel treatment for type 2 diabetes
Vascular Health and Risk Management, 2007 Baptist GallwitzDept. Medicine IV, Eberhard Karls University, Tuebingen, GermanyAbstract: Sitagliptin (Januvia®, Merck Pharmaceuticals) is a dipeptidyl-peptidase inhibitor (DPP-4 inhibitor) that has recently been approved for the therapy of type 2 ...
Baptist Gallwitz
doaj
Pharmacoepidemiology and Drug Safety, Volume 35, Issue 4, April 2026.ABSTRACT Purpose Our purpose was to measure the research output and impact of the Canadian Network for Observational Drug Effect Studies (CNODES). Methods We used OpenAlex to collect metadata on citation counts for all 115 CNODES articles published between January 2011 and March 2022. We obtained the altmetric scores from Altmetric.com.
Alexandra M. Yip +5 more
wiley +1 more source
Meat Proteins as Dipeptidyl Peptidase IV Inhibitors and Glucose Uptake Stimulating Peptides for the Management of a Type 2 Diabetes Mellitus In Silico Study. [PDF]
Nutrients, 2019 Kęska P, Stadnik J, Bąk O, Borowski P.
europepmc +1 more source
Dipeptidyl peptidase-4 and kidney fibrosis in diabetes [PDF]
, 2016 Daisuke Koya, Keizo Kanasaki, Sen Shi
core +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 2978-2987, April 2026.Abstract Aims The precise mechanism of sodium glucose co‐transporter 2 (SGLT2) inhibitor on reno‐protective effect has been still unclear. In this study, we hypothesised that SGLT2 inhibitor prevents diabetic kidney disease via reduction of hypoxia‐induced factors.
Hisashi Makino +14 more
wiley +1 more source
A Cross-Sectional Study Comparing the Prevalence of Bullous Pemphigoid Autoantibodies in 275 Cases of Type II Diabetes Mellitus Treated With or Without Dipeptidyl Peptidase-IV Inhibitors. [PDF]
Front Immunol, 2019 Izumi K, Nishie W, Beniko M, Shimizu H.
europepmc +1 more source
Risk of Dementia in Older Patients with Type 2 Diabetes on Dipeptidyl-Peptidase IV Inhibitors Versus Sulfonylureas: A Real-World Population-Based Cohort Study. [PDF]
J Clin Med, 2018 Kim YG +6 more
europepmc +1 more source